Plan Supporting the Development of Covid-19 Vaccine for Shipment Abroad (Essay Sample)

Plan Supporting the Development of Covid-19 Vaccine for Shipment Abroad
Student's Name
Institutional Affiliation
Course Name and Number
Professor's Name
Date
Introduction
According to the World Trade Organization (WTO), the international trade of human vaccines has expanded by a factor of five since 2005 (Evenett et al., 2021). Complete supply chain and logistics systems are the foundation of effective immunisation programs. Operational vaccine development, manufacture, handling, storage, and stock control; stringent temperature regulation in the supply chain; and proper operation of logistics supervision data structures are all responsibilities of the supply chain (Excler et al., 2021). The purpose is to guarantee that high-quality vaccinations are always available from production through distribution so that vaccination opportunities are never lost because of a lack of vaccines. This paper seeks to lay out a plan for supporting development of a Covid-19 Vaccine for shipment to countries like USA, Canada, Australia, Japan and Brazil
Aim
This paper aims to outline a strategy to facilitate the research, development, regulatory approval, and international distribution of a vaccine against COVID-19 in five countries: The United States of America, Canada, Australia, Japan, and Brazil. The goal of the plan is to ascertain and meet all necessary regulations. The purpose of this paper is to outline a strategy for meeting the regulatory requirements of each country. This includes learning about any clinical trial, production, labelling, or distribution specifications and the regulatory processes that must be followed to gain approval.
Good Manufacturing Practice (GMP), Good Clinical Practice (GCP), and other applicable requirements across jurisdictions